Cliical Trials: Regulatory Notifications & IRB Reporting

Documenting Justification When a Deviation Is Not Reported Externally In the realm of clinical trials, adherence to protocols is paramount for maintaining integrity and compliance. However, situations may arise where protocol deviations occur but are deemed not significant enough to warrant external reporting. This article guides clinical operations, regulatory affairs, and medical affairs professionals on…

Read More “Documenting Justification When a Deviation Is Not Reported Externally” »

Remote and DCT-Specific Considerations for Deviation Notifications Remote and DCT-Specific Considerations for Deviation Notifications As clinical trials increasingly transition to decentralized models, understanding the specific regulatory requirements surrounding protocol deviations becomes crucial. This article provides a comprehensive guide on handling deviation notifications in remote and decentralized clinical trials (DCTs). The guidelines will address the nuances…

Read More “Remote and DCT-Specific Considerations for Deviation Notifications” »

Training Investigators on Their Regulatory Reporting Responsibilities Training Investigators on Their Regulatory Reporting Responsibilities The management of regulatory reporting in clinical trials is a critical aspect that ensures compliance with various regulatory standards and the integrity of study findings. Understanding the responsibilities that investigators hold in this area is essential for clinical operations, regulatory affairs,…

Read More “Training Investigators on Their Regulatory Reporting Responsibilities” »

Tracking Regulatory Feedback on Deviation Notifications Over Time Tracking Regulatory Feedback on Deviation Notifications Over Time Understanding Deviation Notifications in Clinical Trials In clinical trials, it is imperative to adhere to protocols that ensure the integrity, safety, and efficacy of the research. A deviation can be defined as any departure from the trial protocol, which…

Read More “Tracking Regulatory Feedback on Deviation Notifications Over Time” »

Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions Introduction to Reporting in Clinical Trials Clinical trials are essential for advancing medical research and providing new therapies for various diseases. However, with complex regulations and oversight mechanisms in place, understanding the reporting requirements for…

Read More “Using Legal, Regulatory and QA Inputs for Complex Reporting Decisions” »

Inspection Expectations for Documentation of Notifications and Follow-Up Inspection Expectations for Documentation of Notifications and Follow-Up This comprehensive guide aims to delineate the expectations surrounding the documentation of notifications and follow-ups relevant to clinical trials, specifically for clinical operations, regulatory affairs, and medical affairs professionals navigating through the intricate landscape of clinical research regulations in…

Read More “Inspection Expectations for Documentation of Notifications and Follow-Up” »